• PMS50 Indirect Costs of Rheumatoid Arthritis in Serbia Related to Work Absenteeism, Medical Welfare and Rehabilitation Costs

    Nov 1, 2012, 00:00

  • PIN18 Antimicrobial Resistance (AMR) in Thailand- A Systematic Review

    Nov 1, 2012, 00:00

  • PSU22 Health-Related Quality of Life in Prostate Cancer - Comparison of Robot-Assisted and Open Surgery

    Nov 1, 2012, 00:00

  • PSU28 Retrospective Analysis of Liver Transplantation in Brazil

    Nov 1, 2012, 00:00

  • PIH48 Service Uses and Costs of Child and Adolescent Psychiatric Patients Treated with Antipsychotics in Taiwan

    Nov 1, 2012, 00:00

  • PHP85 The Use of Biomarkers in Cancer Trials in Asia

    Nov 1, 2012, 00:00

  • PCV9 Meta-Analysis of the Efficacy and Safety of Stevioside (from Stevia Rebaudiana Bertoni) in Blood Pressure Control in Patients With Hypertension

    Nov 1, 2012, 00:00

  • PRS34 Australian New to Therapy Program Improves Tiotropium (Spiriva) Persistence and Compliance

    Nov 1, 2012, 00:00

  • CV2 Age, Dementia, and Evidence-Based Medication Use After Admission for Acute Coronary Syndrome

    Nov 1, 2012, 00:00

  • PIN33 Corsar-Study (Cost and Resource Utilisation Study in Antiretroviral Treated Patients)

    Nov 1, 2012, 00:00

  • PHP76 Evidence Requirements for Pricing and Reimbursement Decision Making for Orphan Drugs in Asia

    Nov 1, 2012, 00:00

  • PHP37 Prescription Switching from Angiotensin-Converting Enzyme Inhibitors to Angiotensin Receptor Blockers in Taiwan

    Nov 1, 2012, 00:00

  • PUK10 Comparative Cost-Analysis of Six Anticholinergics for the Treatment of Overactive Bladder and Incontinence in Germany

    Nov 1, 2012, 00:00

  • PCN118 Impact of Bone Metastases on Quality of Life in Patients With Castration-Resistant Prostate Cancer (CRPC) at High Risk for Developing Bone Metastases

    Nov 1, 2012, 00:00

  • PRM159 Sensitivity Analysis Versus Uncertainty Analysis in Health Economic Decision Making

    Nov 1, 2012, 00:00

  • PND2 Effect of Cognitive Behavioural Therapy in Multiple Sclerosis Fatigue- A Systematic Review of Randomised Controlled Trials

    Nov 1, 2012, 00:00

  • DU1 A Time Series Analysis of the Effect of the Co-Payment on Pharmaceutical Consumption in Two Italian Regions

    Nov 1, 2012, 00:00

  • PSY9 Real-Life Cost-Analyses of Chronic Low-Back Pain Patients With Neuropathic Pain Components in Denmark

    Nov 1, 2012, 00:00

  • PSS4 Acne and Lifestyle- Results of a Survey on a Representative Sample of the French Population

    Nov 1, 2012, 00:00

  • PR3 Drivers of Pricing and Market Access Decisions - Examples in Selected Countries

    Nov 1, 2012, 00:00

  • CL2 Statistical Considerations in Estimating Survival for Economic Evaluations in Oncology

    Nov 1, 2012, 00:00

  • PIH20 Cost-Effectiveness of Supplemental N-3 in Total Parenteral Nutrition Therapy in the Italian, French, German and UK Context- A Discrete Event Simulation Model

    Nov 1, 2012, 00:00

  • PIH49 Population Access to Rotavirus Vaccination in Developped Countries- Lessons Learned from Current Experience and Potential Implications for the Future

    Nov 1, 2012, 00:00

  • PIN78 Treatment Preference Attributes Among Primary Immunodeficiency Patients and Caregivers Receiving Immunoglobulin Therapy

    Nov 1, 2012, 00:00

  • PIN43 The Use of Futility Rules in Economic Evaluations With Direct Acting Agents (DAA) in the Treatment of Genotype 1 Hepatitis C Virus (HCV) From a Spanish Health Care Perspective

    Nov 1, 2012, 00:00

  • PIH5 Provider Payment and Cost of Treatment for Complicated Delivery Care- Evidence From Case Studies in Indonesia

    Nov 1, 2012, 00:00

  • EX3 A Evaluation of the Effects from China Drug Policy Reform During 2009-2011- Some Success, Many Unintended Effects

    Nov 1, 2012, 00:00

  • PGI3 Treatment of Chronic Hepatitis C Genotype 1 in Poland – Real-Life Data

    Nov 1, 2012, 00:00

  • PRM176 The Value of Further Research- The Added Value of Individual-Level Data

    Nov 1, 2012, 00:00

  • PSS11 Economic Evaluation of Biologic Treatments for Moderate to Severe Psoriasis in Italy

    Nov 1, 2012, 00:00

  • PMS21 Determinants of Total Health Care Costs Associated With Rheumatoid Arthritis Prevalent Cases in Turkey

    Nov 1, 2012, 00:00

  • PMD22 Financial Impact of Adopting Implantable Loop Recorder (ILR) Diagnostics (REVEAL®) for Unexplained Syncope in Portugal- Comparison With Conventional Diagnostic Pathways

    Nov 1, 2012, 00:00

  • PRM85 Internal Validation of the Syreon Diabetes Model

    Nov 1, 2012, 00:00

  • PHS43 Cost-Effectiveness Analysis of Therapeutic Drug Monitoring in Pediatric Patients Diagnosed With Structural-Metabolic Epilepsy

    Nov 1, 2012, 00:00

  • PSY27 A Cost-Effectiveness Comparison of Icatibant and C1-Esterase Inhibitor Concentrate for the Symptomatic Treatment of Acute Attacks of Types I and II Hereditary Angioedema in the UK Setting

    Nov 1, 2012, 00:00

  • PIN5 Immune Reconstitution Inflammatory Syndrome (IRIS) Incidence in Patients Starting Antiretroviral Therapy (ART) Eartlier Versus Later During Tuberculosis (TB) Therapy- A Systemic Review and Meta-Analysis of Cohort Sutdies

    Nov 1, 2012, 00:00

  • PCV8 Assessment of 30-Day Rehospitalization for Acute Myocardial Infarction in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention- A Comparative Effectiveness Study of Clopidogrel and Prasugrel

    Nov 1, 2012, 00:00

  • PIN75 Health-Related Quality of Life of Clostridium Difficile Infection- A Methodological Contribution to Direct Utility Elicitation by TTO

    Nov 1, 2012, 00:00

  • PDB13 Bariatric and Metabolic Surgery in China – Efficacy of Minimally Invasive Procedures

    Nov 1, 2012, 00:00

  • PGI16 Treatment With Prucalopride for Chronic Constipation Improves the Symptoms and Quality of Life of Patients in China

    Nov 1, 2012, 00:00

  • PRM21 Validity and Reliability of the 8-Item Morisky Medication Adherence Scale in Patients Taking Warfarin in Singapore

    Nov 1, 2012, 00:00

  • PDB35 Validation of the Problem Areas in Diabetes Questionnaire Among Patients With Type 2 Diabetes Mellitus in Singapore- a Pilot Study

    Nov 1, 2012, 00:00

  • PIN11 Economic Burden of Invasive Pneumococcal Diseases in Urban China

    Nov 1, 2012, 00:00

  • PSY31 Association Between Teriparatide Adherence and Health Care Utilization and Costs in Real World United States Hip Fracture Patients

    Nov 1, 2012, 00:00

  • PCV104 Relationship Between Comorbidities, Blood Pressure Control and Therapeutic Schemes in Real-Life Setting Hypertensive Patients

    Nov 1, 2012, 00:00

  • PIH33 Utility and Human Capital Loss in Asthma, Chronic Obstructive Pulmonary Disease and Rheumatoid Arthritis – The Impact of Prevalence, Disease Specific Mortality and Utility Decrement on Overall Health Burden

    Nov 1, 2012, 00:00

  • VA4 Found the Missing Link? How to Relate Cohort Models to Observed Population Data

    Nov 1, 2012, 00:00

  • PIN8 A Preliminary Economical Analysis Based on the Early Impact Observed on Genital Warts Burden Reduction Following Quadrivalent HPV Vaccination in Belgium

    Nov 1, 2012, 00:00

  • PMD25 Financial Impact of Adaptive Cardiac Resynchronization Therapy (ACRT) Device Algorithms in the United Kigdom, Germany, Australia and Canada- Are There Savings Associated With Device Selection?

    Nov 1, 2012, 00:00

  • PHS2 Population Risk Stratification- Based on the Cost of Care in Patients With Chronic Diseases

    Nov 1, 2012, 00:00

  • PHP114 Review of Cost Effectiveness Studies of High Budget Impact Drugs (2007-2012)

    Nov 1, 2012, 00:00

  • PGI23 Cost-Effectiveness of Episodic or Maintenance Infliximab Versus Standard Treatment in an Incidence Cohort of Crohn's Disease Patients With 10-Years Follow-Up

    Nov 1, 2012, 00:00

  • PGI20 Cost-Effectiveness of Adalimumab for Treatment of Crohn's Disease in Germany

    Nov 1, 2012, 00:00

  • PHS22 Burden of Invasive Pneumococcal Diseases in Older Adults in the New EU Countries of the Central Europe

    Nov 1, 2012, 00:00

  • PSY45 Social Economic Burden and Health-Related Quality of Life in Patients With Rare Diseases in Europe (BURQOL-RD Project). Spanish Results

    Nov 1, 2012, 00:00

  • PIN83 National Immunization Technical Advisory Group (NITAG) Decision-Making Process for Vaccine Recommendation- Overview and Analysis

    Nov 1, 2012, 00:00

  • PRM169 Internal and External Validity in Economic Modeling- Considerations Based on a Published Example

    Nov 1, 2012, 00:00

  • PSY16 Cost Utility Analysis of Reduced Intensity Hematopoietic Stem Cell Transplantation in Adolescence and Young Adult With Severe Thalassemia Compared to Hypertransfusion and Iron Chelation Program

    Nov 1, 2012, 00:00

  • PHP50 Integrated Closed Intravenous Catheter System Reduces the Occurrence of the Catheter Replacement and the Cost

    Nov 1, 2012, 00:00

  • PRM132 Using Clinical Outcome Assessments and Economic Data to Facilitate Patient Access in Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PCV90 A Novel Conceptual Model of Caregiver Burden in Chronic Heart Failure- A Qualitative Study

    Nov 1, 2012, 00:00

  • PMH3 Caregiver Perceptions on the Burden of Caring for Dementia Patients- Results from a Cross-Sectional Hospital-Based Study in China

    Nov 1, 2012, 00:00

  • PRM24 Economic Valuation of Informal Care – Task Based Approach

    Nov 1, 2012, 00:00

  • PHS73 Willingness of the Health Care Consumers to Pay for Health Care Services – Results from a Contingnet Valuation Study

    Nov 1, 2012, 00:00

  • PCV52 Cost-Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Portugal

    Nov 1, 2012, 00:00

  • PCV54 Economic Evaluation of Rivaroxaban in the Treatment of Deep Vein Thrombosis in Greece

    Nov 1, 2012, 00:00

  • PHS15 Recommendation for Rotavirus Vaccination and Herd Effect- Analyzing Cost Data from a German Statutory Health Insurance

    Nov 1, 2012, 00:00

  • PHP193 Paediatric Use Marketing Authorisation (PUMA)- The Challenges of Cost-Effectiveness Modelling Where Limited Clinical Trial Information is Available

    Nov 1, 2012, 00:00

  • PSU6 Cost-Effectiveness Analysis of Treatment for Rectal Cancer Following Clinical Complete Response

    Nov 1, 2012, 00:00

  • PCV32 The Cost of Diabetes Complications in Belgium

    Nov 1, 2012, 00:00

  • PCN21 Comparative Effectiveness and Cost-Effectiveness Assessment of Erlotinib Versus Gefitinib in First-Line Treatment of EGFR Activating Mutation Positive Non-Small Cell Lung Cancer for Hong Kong

    Nov 1, 2012, 00:00

  • UT1 The Calculation of Quality of Life Utilities for Acute Leukemia- A Comparison Between EQ5D-5L and QlQ-C30

    Nov 1, 2012, 00:00

  • PCN12 Meta Analytic Comparison of Breast Cancer Risk in Diabetic Women- Important Differences Between Asian and Caucasian Women Suggest Risk Management Startegies

    Nov 1, 2012, 00:00

  • UT2 Mapping DLQI on EQ-5D in Psoriasis – Transformation of Skin-Specific Health-Related Quality of Life Into Utilities

    Nov 1, 2012, 00:00

  • PHP115 The Sharp Decrease of Drug's Access to Reimbursement in France in 2011

    Nov 1, 2012, 00:00

  • PMH12 Are Disease Related Costs of Care for Major Depression in Germany Overestimated? – Using Claims Data to Assess the Influence of Disease Severity and Comorbidity

    Nov 1, 2012, 00:00

  • PMS35 Cost-Effectiveness of Tocilizumab for the Treatment of Active Rheumatoid Arthritis (RA) Patients With Inadequate Response to Anti-TNF Treatment in Turkey

    Nov 1, 2012, 00:00

  • PSS32 Predictors of Biologic Treatment in Psoriasis Population

    Nov 1, 2012, 00:00

  • PRM161 A Paradigm Shift in Health Economic Evaluations for Developing Countries - Optimization Modelling for Assessing Which Mix of Malaria Prevention Strategies Achieves a Defined Public Health Target at the Lowest Budget

    Nov 1, 2012, 00:00

  • PCN11 Decreased Risk of Prostate Cancer in Type 2 Diabetes Patients- A Meta-Analysis of Cohort Studies

    Nov 1, 2012, 00:00

  • PCN52 English Hospital Costs for Anal Cancer- Preliminary Results from an Investigation Using Hospital Episodes Statistics (HES)

    Nov 1, 2012, 00:00

  • PCV81 Awareness of Serious Consequences of Non-Compliance and Self-Reported Adherence to Antipaltelet Therapy After Percutaneous Coronary Intervention

    Nov 1, 2012, 00:00

  • PHP142 Drug Shortages Around the World and the Underlying Reasons

    Nov 1, 2012, 00:00

  • PHS33 Cost Analysis of Dialysis Practice in Turkey

    Nov 1, 2012, 00:00

  • PCV116 Impact of the Type of Drug Insurance on Cost of Statins and Anti-Depressants

    Nov 1, 2012, 00:00

  • PIN7 Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Complicated Skin and Soft Tissue Infections (CSSTI)- A Network Meta-Analysis (NMA)

    Nov 1, 2012, 00:00

  • PRM149 A Random Utlity Model Using a Transaction Cost Politics Approach to Adjust Health Systems to Economic Transition

    Nov 1, 2012, 00:00

  • PMD20 Budget Impact of Drug Eluting Balloons for Intermittent Claudication From Superficial Femoral Artery Disease in the United States Health Care System

    Nov 1, 2012, 00:00

  • PHP62 Modify Change Order System to Reduce Drug Return Rate in Inpatient Pharmacy

    Nov 1, 2012, 00:00

  • PHP100 Prevention or Treatment? Preferences of the Australian Public for Health Technology Assessment Funding Criteria

    Nov 1, 2012, 00:00

  • PCN82 Cost-Effectiveness Analysis of Erlotinib Versus Platinum Based Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer EGFR Activating Mutations

    Nov 1, 2012, 00:00

  • PMH20 Metabolic Consequences and Cost-Effectiveness of Asenapine in the Treatment of Bipolar Disorder

    Nov 1, 2012, 00:00

  • PCV19 The Burden of Diabetes Mellitus in Belgium- A Retrospective Database Study

    Nov 1, 2012, 00:00

  • PDB63 Improvements in Health-Related Quality of Life in Acromegaly With Pasireotide LAR and Octreotide LAR- Results From a Large, Randomized, Double-Blind Phase III Trial

    Nov 1, 2012, 00:00

  • PIN44 Cost-Effectiveness of Posaconazole Compared to Fluconazole/Itraconazole for the Prevention of Invasive Fungal Infections in Neutropenic Patients

    Nov 1, 2012, 00:00

  • PCV35 Correlation Among Pre-Operative Conditions, Waiting Time and Outcome of Elective Patients in Cabg Waiting List in Harapan Kita Hospital 2011

    Nov 1, 2012, 00:00

  • PCN108 Quality of Life and Patient Preferences in Platinum Sensitive Ovarian Cancer

    Nov 1, 2012, 00:00

  • PSS3 The Efficacy of Epidermal Growth Factor in Burn Wound Treatment

    Nov 1, 2012, 00:00

  • PCN150 Comparisons of QALYs Gained, Cost Per QALY Gained and ASMRs for 38 Anticancer Drugs in France and the UK- Vive La Difference?

    Nov 1, 2012, 00:00

  • PRS2 Meta-Analysis of the Effects of Theophylline on Kidney Function in Neonates With Perinatal Asphyxia

    Nov 1, 2012, 00:00

  • PCV19 Hospitalization Costs and Their Predictors in Patients With Venous Thromboembolism in China

    Nov 1, 2012, 00:00

  • PHP86 Cost-Effectiveness in Health Care Programs- A Literature Review

    Nov 1, 2012, 00:00

  • PHP64 Evaluation of Public Perception Towards Medicine Quality and Prices in Afghanistan

    Nov 1, 2012, 00:00

  • PRM47 Cost-Effectiveness Uncertainty Analysis Methods- A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information

    Nov 1, 2012, 00:00

  • PHS92 Allocation of Research Funding in Health Care in Relation to Disease Burden in Europe

    Nov 1, 2012, 00:00

  • PCN58 Health Economic Impact of Colorectal Cancer

    Nov 1, 2012, 00:00

  • PDB22 Potential Budget Impact of Linagliptin in France Estimated From Current Pattern of Dipeptidyl Peptidase 4 Inhibitors Prescriptions

    Nov 1, 2012, 00:00

  • PND50 Estimation of the Effect of Dalfampridine Extended Release on Health Utility in Patients With Multiple Sclerosis Using Two Equations for Mapping the MSWS-12 to the EQ-5D

    Nov 1, 2012, 00:00

  • DB3 How a Fear of Hypoglycemia Influences Health-Related Quality of Life in Type 2 Diabetes Mellitus Patients in Spain? Hipoqol-II Study

    Nov 1, 2012, 00:00

  • PCV115 Burden of Hypertension in Selected EU Countries- 2010-2025

    Nov 1, 2012, 00:00

  • PCN78 Cost-Effectiveness of Plerixafor Plus GCSF for Mobilization of Peripheral Blood Stem Cells in Patients With Myeloma and Lymphoma in Spain

    Nov 1, 2012, 00:00

  • PSS25 Validation of the Patient Benefit Index (PBI) for the Assessment of Patient-Defined Benefit in the Treatment of Psoriasis

    Nov 1, 2012, 00:00

  • PHP77 Health Expenditure and Drug Expenditure - Comparison of Two Western Balkans Countries

    Nov 1, 2012, 00:00

  • PCV80 A Retrospective Study of Comparing Compliance and Persistence of Free Combination Antihypertensive Therapy Versus Single-Pill Combination- Korean Case

    Nov 1, 2012, 00:00

  • PCN104 Profile of Patients and Health Care Costs Associated With Cancer Treatment From a Medical Cooperative in the State of São Paulo, Brazil

    Nov 1, 2012, 00:00

  • PHP9 Drug Pricing in Bosnia and Herzegovina

    Nov 1, 2012, 00:00

  • PCN28 Statin Use and Risk of Breast Cancer- A Meta-Analysis of 24 Observational Studies

    Nov 1, 2012, 00:00

  • PHP177 Characteristics of Patients Not Consuming Pharmacological Resources Due to a Lack of Drug Prescription During Their Hospital Admission

    Nov 1, 2012, 00:00

  • PMS29 Cost Effectiveness of Adalimumab Versus Golimumab and Placebo in Ankylosing Spondylitis in Italy

    Nov 1, 2012, 00:00

  • PIN9 A Multi-Center, Retrospective, Chart Review Study to Compare Direct Health Care Costs of Treatment Experienced Patients With HV/AIDS Before and After Triple Class Failure in Thailand

    Nov 1, 2012, 00:00

  • PHP59 Exploring the Health and Living Standards of Those Who Don't Report Their Migration Status in a Population-Based Survey- The Case of Chile

    Nov 1, 2012, 00:00

  • PHP106 Diffusion of Non-Guideline Experience-Based Chemotherapy Care

    Nov 1, 2012, 00:00

  • PRM131 How Might Experience-Based Utility Measures Influence Reimbursement Decisions?

    Nov 1, 2012, 00:00

  • PCN129 Emerging Market Access Trends- Pricing and Coverage of Targeted Cancer Therapies in Russia (2011-2012)

    Nov 1, 2012, 00:00

  • PMD5 Clinical and Cost-Effectiveness of Third-Generation, Implantable Left Ventricular Assist Devices for People With End-Stage Heart Failure- A Systematic Review

    Nov 1, 2012, 00:00

  • PMS18 Importance of COI Studies in the Health Care-Related Decision-Making Process Through the Example of Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PMS45 Exercise Therapy, Manual Therapy, or Both, for Management of Osteoarthritis of the Hip or Knee- Economic Evaluation Alongside a Randomized Clinical Trial

    Nov 1, 2012, 00:00

  • PIH50 Trends in Post-Marketing Commitments Related to Pregnancy and Lactation

    Nov 1, 2012, 00:00

  • PMH51 Real World Add-on and Switch Patterns for Different Formulation of Methylphenidate

    Nov 1, 2012, 00:00

  • PRM138 A Propensity to Get It Right. A Monte Carlo Simulation Study Comparing Statistical Methods to Obtain Correct Cost-Effectiveness Estimates in Observational Studies

    Nov 1, 2012, 00:00

  • PMS64 Comparative Efficacy of Tocilizumab and aTNF Biologic Monotherapies on Patient Reported Outcomes (PROs) in RA Patients Who Have Shown an Inadequate Response to Conventional DMARDs (DMARD-IR)- A Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PDB47 Effects of Patient-Reported Non-Severe Hypoglycaemia on Health Care Resource Use and Work-Time Loss in Seven European Countries

    Nov 1, 2012, 00:00

  • PMH17 Economic Burden in Schizophrenia- A Literature Review

    Nov 1, 2012, 00:00

  • PMS1 Characteristics of Patients With Rheumatoid Arthritis in Turkey- Results from the Turkish League Against Rheumatism RA Registry

    Nov 1, 2012, 00:00

  • PRM16 Evaluation of Personalized Breast Cancer Test-Treatment Strategies - A Cross-Validation Study Between a Discrete-Event Simulation and a Markov Model

    Nov 1, 2012, 00:00

  • PIN10 Fourth Year Post-Rotavirus Vaccination in Belgium- Decrease of Rotavirus-Positive Stool Samples in Hospitalised Children

    Nov 1, 2012, 00:00

  • PRM74 Cost Effectiveness of Tirofiban in Acute Coronary Syndrome

    Nov 1, 2012, 00:00

  • PUK17 Cost-Mimimization Analysis of Pazopanib Versus Sunitinib, Sorafenib and Bevacizumab+ Interferon á-2a for Patients With Metastatic Renal Cell Carcinoma

    Nov 1, 2012, 00:00

  • PIN52 Pharmacoeconomical Aspects of Treating Acute Bronchitis Among Adults

    Nov 1, 2012, 00:00

  • PCN107 Persistence in First Line Treatment of Metastatic Renal Cell Carcinoma in Routine Care in Germany

    Nov 1, 2012, 00:00

  • PCN121 Decitabine Reduces Transfusion Dependence in Older Patients With Acute Myeloid Leukaemia- Results From a Post-Hoc Analysis of a Randomised Phase III Trial

    Nov 1, 2012, 00:00

  • PHP67 Review of the Currently Listed Drugs in South Korea

    Nov 1, 2012, 00:00

  • PIN22 Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Persons Over 50 Years of Age With Underlying Chronic Medical Conditions in Finland

    Nov 1, 2012, 00:00

  • PCN98 Health Outcome Gains and Costs Offset Associated With Everolimus for the Treatment of Hormone-Receptor–Positive (HR+) HER2-Negative (HER2–) Advanced Breast Cancer (ABC)

    Nov 1, 2012, 00:00

  • PSU21 Sentinel Lymph Node Biopsy Less Expensive Than Axillary Lymph Node Dissection in Early Breast Cancer Staging

    Nov 1, 2012, 00:00

  • PHP111 Factors Predicting Reimbursement Decisions on Orphan Drugs in Eight Countries

    Nov 1, 2012, 00:00

  • PRM98 Optimizing Discrete Choice Experiment Designs Using Simulations

    Nov 1, 2012, 00:00

  • PHP157 To What Extent Does the Federal Joint Committee Follows the Evidence Based Recommendations by IQWiG

    Nov 1, 2012, 00:00

  • PHP173 Disentangling the Relationship Between Disability, Socioeconomic Status and Social Capital in Chile- A Population-Based Study

    Nov 1, 2012, 00:00

  • PMD91 Scenario Analysis and Real Options Modeling of Home Brain Monitoring in Epilepsy Patients

    Nov 1, 2012, 00:00

  • PRM122 Atopic Dermatitis on Families- Creation of a Specific Burden Questionnaire

    Nov 1, 2012, 00:00

  • PMD33 The Impact of Three Different Imaging Strategies on Surgery Planning for Patients With Colorectal Cancer Liver Metastases

    Nov 1, 2012, 00:00

  • PHP69 United States Valuation of Child Health Outcomes

    Nov 1, 2012, 00:00

  • PCV106 Affordability of Anti-Hypertensive Medication in Egypt Under Current Reimbursement Systems

    Nov 1, 2012, 00:00

  • PCV6 Comparison Rivaroxaban with Other Antithrombotic Agents- Effectiveness and Safety of Prophylactic Antithrombotic Agents After Major Orthopedic Surgeries in Taiwan

    Nov 1, 2012, 00:00

  • PMD92 Inhaler Use in Five European Countries- Analysis of Sales Data From Q4 2005 to Q4 2011

    Nov 1, 2012, 00:00

  • PIN17 Tuberculosis Treatment Outcomes in Four States of Malaysia

    Nov 1, 2012, 00:00

  • PHS31 Determination of the Annual Health Insurance Cost of Outpatient Care Physiotherapy Services for Musculoskeletal and Connective Tissue Diseases

    Nov 1, 2012, 00:00

  • PUK16 Cost-Effectiveness of Ketosteril Treatment in Stage 3-4 CKD Patients

    Nov 1, 2012, 00:00

  • PMD6 Extracorporeal Photopheresis for the Treatment of Patients With Acute or Chronic Graft Versus Host Disease (GvHD), Refractory to Corticosteroids – A Sytematic Review

    Nov 1, 2012, 00:00

  • PRM116 Payer and Patient Perceptions of Medication Value and the Role of Patient-Reported Outcomes

    Nov 1, 2012, 00:00

  • PA1 Assessing the Progression of the UK NHS Health Care Reforms and the Impact on Health Care Delivery

    Nov 1, 2012, 00:00

  • PRM68 Comparative Computation Speed of Excel, Visual Basic for Applications, R, and Java in Execution of a Microsimulation Model With Probabilistic Sensitivity Analysis

    Nov 1, 2012, 00:00

  • PHS37 Cost Minimization Analysis in the Treatment of Community Acquired Pneumonia in Ukraine

    Nov 1, 2012, 00:00

  • PDB58 The Psychometric Performance of the EQ-5D, SF-6D and Diabetes Health Profile (DHP-18) in Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PRM6 The UK Contribution to Real World Research- Review of Published Data at ISPOR, Madrid 2011

    Nov 1, 2012, 00:00

  • PMD28 Comparing the Cost and Diagnostic Efficiency of Gadoxetic Acid-Enhanced MRI Versus Extracellular Contrast Media-Enhanced MRI and Multidetector Computed Tomography in Patients With Suspected Hepatocellular Carcinoma in Thailand and Kor ...

    Nov 1, 2012, 00:00

  • PSY9 Medical Cost of Organ Damage Due to Systemic Lupus Erythematosus

    Nov 1, 2012, 00:00

  • PIN55 How Should We Target Cost-Efficacy in the Treatment of HIV-1 Naïve Patients With Recommended Therapies Based on NNRTIS in Spain?

    Nov 1, 2012, 00:00

  • PHP109 Practice Change in Italian Community Pharmacy- An Analysis of Managerial Implication

    Nov 1, 2012, 00:00

  • PRS32 Allergy Patients Treated With Immunotherapy Experience Increased Quality of Life and Fewer Sick Days After One Year

    Nov 1, 2012, 00:00

  • PDB14 Characteristics of the Aboriginal People with Diabetes in the South-Western of Ontario, Canada

    Nov 1, 2012, 00:00

  • PUK7 Cost of Illness of Overactive Bladder Syndrome in Hungary

    Nov 1, 2012, 00:00

  • PIH30 Potentially Inappropriate Prescribing and Adverse Health Outcomes in Community Dwelling Older Populations

    Nov 1, 2012, 00:00

  • PSU18 Assessment of the Resource Use and Costs Associated With Parathyroidectomy Surgery for Secondary Hyperparathyroidism in End Stage Renal Disease in the UK

    Nov 1, 2012, 00:00

  • PHP25 Market Analysis of Antibiotics Consumption in Northern Part of Iran During 2001-2010

    Nov 1, 2012, 00:00

  • PCN147 A Cross European Comparison of Eribulin Reimbursement Decisions

    Nov 1, 2012, 00:00

  • PMS14 Impact of Severity Index for Rheumatoid Arthritis on Health Care Costs and Utilizations in Patients With Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PMS9 Budget Impact of Using Sugammadex for the Routine Reversal of Neuromuscular Blockade in a Greek Health Care Setting

    Nov 1, 2012, 00:00

  • PHP196 Stakeholder Involvement in Health Technology Assessment (HTA) of Novel Medical Devices

    Nov 1, 2012, 00:00

  • PIH4 Network Meta-Analysis of Pharmacological Interventions to Prevent Venous Thromboembolism Following Elective Knee and Hip Replacement Surgery- Why Extend the Network?

    Nov 1, 2012, 00:00

  • PDB24 Cost- Effectiveness Analysis of Pregabalin in the Treatment of Diabetic Peripheral Neuropathy

    Nov 1, 2012, 00:00

  • PCN9 Epidemiology of Venous Thromboembolism Among Cancer Patients in Taiwan

    Nov 1, 2012, 00:00

  • PSY11 Swedish Adaptation of Czech Pharmacoeconomic Comparison of Treatments in Haemophilia Patients With Inhibitors

    Nov 1, 2012, 00:00

  • PUK9 Direct and Indirect Cost of Urge Urinary Incontinence With and Without Pharmacotherapy

    Nov 1, 2012, 00:00

  • PCV117 A Ten Years Longer Life- A Therapeutic Education Program for Hypertensive Patients

    Nov 1, 2012, 00:00

  • PSY14 Long-Term Medical Costs and Life Expectancy of Acute Myeloid Leukaemia- A Probabilistic Decision Model

    Nov 1, 2012, 00:00

  • PRM57 Developing BASDAI and BASFI Predictive Equations From Clinical Trial Data of Golimumab for Severe, Active Ankylosing Spondylitis in Adults

    Nov 1, 2012, 00:00

  • PDB12 How Hypoglycaemic Events Can Influence Diabetic Patients' Weight and Affect Hba1C Control

    Nov 1, 2012, 00:00

  • ME2 Validation of the Kidney Disease and Quality of Life Questionnaire (KDQOL-36) in Haemodialysis Patients in Singapore

    Nov 1, 2012, 00:00

  • PCV91 The Impact of Atrial Fibrilation Symptoms in the Health Related Quality of Life in Spanish Population (Ulises Study)

    Nov 1, 2012, 00:00

  • PCV121 Relationship Between Primary Care Physicians Profile, Self-Perceived Health and Recommendations to Their Patients

    Nov 1, 2012, 00:00

  • PMS17 The Societal Cost for RA Before and After the Introduction of Biological Drugs- a Swedish National Register Study for 1990-2010

    Nov 1, 2012, 00:00

  • RU2 Potential Time Savings With Trastuzumab Subcutaneous (SC) Injection Versus Trastuzumab Intravenous (IV) Infusion- Results from Interviews Conducted As Part of a Time-and-Motion Study (TM) Across 17 Sites

    Nov 1, 2012, 00:00

  • PRM71 Differential Time Preference for Money, Life Years and Quality of Life- An Empirical Pilot Study

    Nov 1, 2012, 00:00

  • PDB69 Diffusion of New Technologies Post Reimbursement – Monitoring the Use of Liraglutide in Primary Care

    Nov 1, 2012, 00:00

  • PCN145 Observational Macro Analysis on the Aggregated Cigarette Price Elasticity in Denmark 1978-2010

    Nov 1, 2012, 00:00

  • PMH8 A Review of Consequences of Relapse in Schizophrenia

    Nov 1, 2012, 00:00

  • PHP24 Assessment of the in Excess NHI-Covered Medications of Outpatients in a 2000-Bed Medical Center in Taiwan

    Nov 1, 2012, 00:00

  • PSS33 Treatment Patterns of Biologic Use in Psoriasis Patients in England

    Nov 1, 2012, 00:00

  • PHP3 Adherence to the Clinical Practice Guidelines in the Management of Chronic Ischemic Heart Failure in a District Hospital

    Nov 1, 2012, 00:00

  • PHP136 Generic Price Linkage As a Policy Choi Review of Recent Developments

    Nov 1, 2012, 00:00

  • PGI12 Assessment of Knowledge, Attitude and Practices of Hepatitis B Patients Towards Their Disease

    Nov 1, 2012, 00:00

  • PHP10 The Margin Between Acquisition Costs and Reimbursement Prices of Generic Drugs (yakkasa) in Japan- Current Status and Determinants

    Nov 1, 2012, 00:00

  • PND14 Budgetary Impact of the Treatment of Relapsing-Remitting Multiple Sclerosis in Spain

    Nov 1, 2012, 00:00

  • PRM56 Development of a Conceptual Model for Use in Economic Modelling of Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2012, 00:00

  • PCN133 Utilisation of Antineoplatic Agents Involved in Treatment of NSCLC in Slovak Republic Within 2008-2011

    Nov 1, 2012, 00:00

  • PRM172 The Value of Personalized Medicine- It is More About Unveiling the Performance of the Companion Diagnostic

    Nov 1, 2012, 00:00

  • PRM30 Hospitalization Registry and Costs of Benign Prostatic Hyperplasia Patients (BPH) Based on a Public Database (DATASUS) in Brazil

    Nov 1, 2012, 00:00

  • PND31 Economic Value of Slowing Parkinson's Disease in Germany- Modeling Progression Through Hoehn and Yahr Stages

    Nov 1, 2012, 00:00

  • PHP14 The Implementation of Essential Medicine Policy in China- Pros and Cons

    Nov 1, 2012, 00:00

  • PGI6 A Budget Impact Analysis to Estimate the Economic Impact of Lactest for the Diagnosis of Hypolactasia in Spain

    Nov 1, 2012, 00:00

  • PHP84 Lung Cancer Treatment- A Paradigm Shift to Targeted Therapies in Clinical Trial Settings in Asia

    Nov 1, 2012, 00:00

  • PHP163 Assessing the Quality of Manufacturers' Searches in NICE Single Technology Appraisals by Evidence Review Groups

    Nov 1, 2012, 00:00

  • PHP74 Cost-of-Illness of Patient-Reported Adverse Drug Events – a Population-Based Survey

    Nov 1, 2012, 00:00

  • PMH10 Cost-Effectiveness of Antidepressant Based on Discrete Event Simulation Modeling in Treatment of Major Depressive Episodes- A Comparison of Agomelatine Versus Escitalopram-Venlafaxine

    Nov 1, 2012, 00:00

  • PHP94 Determinants of Drug Therapy Problems among Medicaid Patients Receiving a Telephonic Medication Therapy Management Program

    Nov 1, 2012, 00:00

  • PCN120 Quality of Life Among German Patients With Metastatic Castration-Resistant Prostate Cancer

    Nov 1, 2012, 00:00

  • PHP61 To Evaluate the Effectiveness and Cost of Pharmaceutical Care Volunteer Set Up by Tainan City Government Involved in the Hospital Attached Home Care Patients

    Nov 1, 2012, 00:00

  • PCN25 Utility of Advanced Non-Small Cell Lung Cancer Patients in Thailand- Preliminary Study

    Nov 1, 2012, 00:00

  • PCV16 Associations Between Patient Demographics, Pharmacotherapy Use, and Cost, Resource Utilization, and Quality-of-Life Burden in Adult Cardiac Arrhythmia Patients

    Nov 1, 2012, 00:00

  • PHP44 Public Financing of Medicines in Portugal (2007-2011)- Accessibility to Medicinal Products with New Molecules or New Therapeutic Indications

    Nov 1, 2012, 00:00

  • PCV111 Unmet Therapeutic Needs for Patients With Dyslipidemia According to ATP III Guidelines

    Nov 1, 2012, 00:00

  • EX4 Recent Trends in Community Pharmacy Payment of National Health Insurance in South Korea

    Nov 1, 2012, 00:00

  • PRM105 Predicting Subjective Antimuscarinic Effectiveness on Symptoms of Overactive Bladder Using the Eight-Item Overactive Bladder Awareness Tool (OAB-V8)

    Nov 1, 2012, 00:00

  • PDB15 A1C Variability is Associated With the Risk of Developing New Diabetes for the Healthy Adults

    Nov 1, 2012, 00:00

  • RU4 Universal Versus Selective Screening for Down'S Syndrome- An Economic Evaluation of Resource Use and Costs by Screening Policy

    Nov 1, 2012, 00:00

  • PND10 Faster Cognitive Decline is Associated With Decreasing Survival in Patients With Alzheimer'S Disease

    Nov 1, 2012, 00:00

  • PDB20 Estimating the Direct Medical Costs Associated with Diabetes-Related Complications in Indonesia

    Nov 1, 2012, 00:00

  • PDB64 The Avoidance of Weight Gain is Important for Oral Type 2 Diabetes Treatments in Sweden and Germany- A Patient Preference Study

    Nov 1, 2012, 00:00

  • PRM16 Access to Cost Data Capture Using Public Database, Website and Literature in Germany, France, Spain and USA

    Nov 1, 2012, 00:00

  • PCV75 Complementing Data for Rare Diseases - Comparing Data From National Registries to a European Chart Abstraction Study for Patients With Chronic Thromboembolic Pulmonary Hypertension

    Nov 1, 2012, 00:00

  • PCN33 Progression-Free Survival as a Surrogate for Overall Survival in Metastatic Breast Cancer

    Nov 1, 2012, 00:00

  • PCV97 Burden of Dyspepsia among Patients With Atrial Fibrillation in Japan

    Nov 1, 2012, 00:00

  • PRM60 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for 1st- Line Chronic Myeloid Leukaemia

    Nov 1, 2012, 00:00

  • PCV108 Analysis of Outpatient Utilization and Costs of Antithrombotic Drugs in Poland – Implications for Pharmaceutical Pricing and Reimbursement Policy

    Nov 1, 2012, 00:00

  • PIH3 Pregnancy Outcomes Folowing Exposure to Serotonin Reuptake Inhibitors- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PHP111 Development of National Medicine Brand Substitution Guidelines and Pilot Assessment of Its Adoptability among Community Pharmacist and General Practitioners in the State of Penang, Malaysia

    Nov 1, 2012, 00:00

  • VA2 Correlates of Protection for Vaccines- When Does a Correlate Equal Protection?

    Nov 1, 2012, 00:00

  • PHP39 Prescription Filling on Outpatient Health Care Departments- An Indonesia Family Life Survey (IFLS) Year 2007 – 2008 Based Study

    Nov 1, 2012, 00:00

  • PIN85 Burden of Methicillin-Resistant Staphylococcus Aureus Bacteremia on Hospitals in the United States- Results From a National Database

    Nov 1, 2012, 00:00

  • CL4 Drug Switching Events Among Users of NSAIDS With or Without Gastro-Protective Drugs As an Early Determinant of Dissatisfaction From Gastrointestinal Adverse Events

    Nov 1, 2012, 00:00

  • PMH34 Persistence in Use of Antidepressants in Pregnant Women Enrolled in Medicaid in the United States

    Nov 1, 2012, 00:00

  • PCN24 Treatment and Response Patterns in Chronic Myeloid Leukemia- Evidence from a Retrospective Study in Canada, Australia, and South Korea

    Nov 1, 2012, 00:00

  • PSU4 Regional Variation in Angiogram Use for Patients Who Underwent Coronary Artery Bypass Graft Surgery

    Nov 1, 2012, 00:00

  • PIN40 Cost-Effectiveness of Boceprevir-Based Treatment of Chronic Genotype 1 Hepatitis C Virus (HCV) Infection From the Perspective of the German Statutory Health Insurance (SHI)

    Nov 1, 2012, 00:00

  • PUK12 Cost-Effectiveness of Immunosuppressive Regimens in Renal Transplant Recipients in Germany- A Model Update

    Nov 1, 2012, 00:00

  • PND35 Buccolam® (Licensed Oromucosal Midazolam) Versus Rectal Diazepam for Acute Epileptic Seizures- Italian Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in Italy

    Nov 1, 2012, 00:00

  • MA2 Observation of Persistence Rates and Potential Cost Savings Associated With Certolizumab Pegol Treatment for Rheumatoid Arthritis in England, Wales and Northern Ireland Clinical Practice

    Nov 1, 2012, 00:00

  • PMS23 Health Related Quality of Life, Measured by the Short Form-36, of Patients with Rheumatoid Arthritis and Ankylosing Spondylitis in an Urban Population of China

    Nov 1, 2012, 00:00

  • PRM96 Reliability of a Patient-Reported Adverse Drug Event Questionnaire

    Nov 1, 2012, 00:00

  • PRM167 The Value of Choice in a Collectively Funded Health System- An Extended Analytical Approach to Examine the Conflict Between Decisions at Individual and Societal Level

    Nov 1, 2012, 00:00

  • PIN12 Burden of Disease and Serotype Distribution Associated With Reportable Invasive Streptococcus Pneumoniae Pneumonia in Norway, 2007–2009

    Nov 1, 2012, 00:00

  • Editorial Board

    Nov 1, 2012, 00:00

  • PCN5 Cabazitaxel Plus Corticosteroids in Comparison to Corticosteroids Alone for the Treatment of Metastatic Hormone Refractory / Castration-Resistant Prostate Cancer (mHRPC)

    Nov 1, 2012, 00:00

  • PND68 Comparison of Hospitalizations Among Parkinson'S Patients Who Initiated Therapy With a Dopamine Agonist or Rasagiline- Evidence From the Medicare Supplemental Database

    Nov 1, 2012, 00:00

  • PRS40 Are Disease Management Programs for COPD Cost-Saving?

    Nov 1, 2012, 00:00

  • PDB59 Content Validity of a New Patient-Reported Outcome Instrument to Assess Hypoglycemia- The Hypoglycemia Perspectives Questionnaire

    Nov 1, 2012, 00:00

  • PRM31 Chinese Valuation of EQ-5D Health States With the Time Trade-Off Method

    Nov 1, 2012, 00:00

  • PHP188 Funding the Unfundable- The Australian Approach for Specialty Pharmaceuticals

    Nov 1, 2012, 00:00

  • PHP13 The Effect of Law for Economical Use of Medications 2006 on the Number of Pharmacies Between 2007-2010

    Nov 1, 2012, 00:00

  • PCV76 Standard Costs and Resources Allocation in Attainment of Target Lipid Levels among Experienced Statin Users- Results From the STAR Study (Statins Target Assessment in Real Practice)

    Nov 1, 2012, 00:00

  • PMH55 Payer Value in Alternative Treatment Formulations- Access to New Medicines in Schizophrenia

    Nov 1, 2012, 00:00

  • NI1 Three Years of Nice Scientific Advi Comprehensive Analysis of Requests to the Programme

    Nov 1, 2012, 00:00

  • PRM133 Reviewing Translatability Prior to Translation and Linguistic Validation of Pros

    Nov 1, 2012, 00:00

  • PCV43 Fair Cost-Benefit Evaluation of Health Care- A Case Study of Blood Pressure Lowering Drugs in France

    Nov 1, 2012, 00:00

  • PHP98 The Industry Survey Results Regarding Korea PE Guideline Revision

    Nov 1, 2012, 00:00

  • PRM171 Optimal Shopping- An Evauation of Decision Rules in Cost-Effectiveness Analysis (CEA)

    Nov 1, 2012, 00:00

  • PSS17 Clinical and Economic Analysis of Linezolid for the Treatment of Methicillin Resistant Staphylococcus Aureus Confirmed Complicated Skin and Soft Tissue Infections Under the Brazilian Private Health Care System

    Nov 1, 2012, 00:00

  • PHP113 Utilization of FPG, HbA1C and Self-Monitoring of Blood Glucose (SMBG) in Community Health Centers in the Shanghai Area

    Nov 1, 2012, 00:00

  • CL4 Marginal Structural Models Used in Estimating Cost-Effectiveness of Time-Varying Drug Therapy Using Adimistrative Databases. The Case of Statin in Secondary Prevention

    Nov 1, 2012, 00:00

  • PMD27 Budget Impact of Selecting Cardiac Resynchronization Therapy (CRT) Devices With Adaptive (“ACRT”) Programming Algorithms Under the United States Medicare Payment Setting

    Nov 1, 2012, 00:00

  • PCV72 Cost-Effectiveness of Rivaroxaban Versus Acenocumarol in the Stroke Prevention in Patients With Non-Valvular Atrial Fibrilation in the Spanish Setting

    Nov 1, 2012, 00:00

  • PSY49 Treatment Patterns in Psoriatic Arthritis (PSA) Patients Newly Initiated on Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)

    Nov 1, 2012, 00:00

  • PHP94 Effectiveness and Cost-Benefit of a Bupivacaine Physician Educational Programme in Minimizing the Spinal Anesthesia Failure Rate- Report from a Tertiary-Care Hospital in Central Taiwan

    Nov 1, 2012, 00:00

  • PCN27 Analysis of Prevalence and Treatment of Multiple Myeloma in German Statutory Sick Funds Claim Data

    Nov 1, 2012, 00:00

  • PSS1 Persistence With Statin Therapy and Risk of Psoriasis- A Population-Based Retrospective Cohort Study

    Nov 1, 2012, 00:00

  • PGI29 Cost of Chronic Hepatitis C (HCV) in Poland – Health Care Professionals Survey

    Nov 1, 2012, 00:00

  • PIN1 Effect of Antitubercolosis Treatment on Lever Enzymes

    Nov 1, 2012, 00:00

  • CA4 A Comparison of Patient and General-Population Utility Values for Advanced Melanoma in Health Economic Modelling

    Nov 1, 2012, 00:00

  • PMD49 Cost-Effectiveness of the TLC-NOSF Dressing in Venous Leg Ulcers

    Nov 1, 2012, 00:00

  • PHP16 Removing the Barrier of Cost to Smoking Cessation Medications Under the Affordable Care Act of 2010

    Nov 1, 2012, 00:00

  • PCV98 Health Related Quality of Life and Age in Hypertensive Patients- Self-Perception and Evaluation by Professionals. The Equality Study

    Nov 1, 2012, 00:00

  • PMD79 A Population-Based Study on the Use of Blood Glucose Monitoring Test Strips

    Nov 1, 2012, 00:00

  • NI2 The Use of Off-Label Comparators in Nice Appraisals – An Indirect Endorsement?

    Nov 1, 2012, 00:00

  • PRS29 Queuing Statistical Model - A New Tool for Preliminary Cost-Effectiveness Assessments

    Nov 1, 2012, 00:00

  • PIN20 Budget Impact of Backbone Choice in Italian Treatment- Naïve, HIV-Infected Patients

    Nov 1, 2012, 00:00

  • PGI9 Analysis of Adherence With Oral 5-Aminosalicylic Acid (5-ASA) Therapy in Patients with Ulcerative Colitis (UC) in a Uk Pharmacy Database

    Nov 1, 2012, 00:00

  • PRM124 Translation of the Alcohol Timeline Followback (TLFB) in 4 Languages

    Nov 1, 2012, 00:00

  • PRM17 Economic Evaluation of Vaccines- Considerations on Evidence, Discounting, Models and Futures Challenges

    Nov 1, 2012, 00:00

  • PCN140 The Evaluation of Health Care Resource Utilization in Patients With Metastatic Castration Resistant Prostate Cancer- Results of a Multinational Observational Study

    Nov 1, 2012, 00:00

  • PUK6 The Economic Burden of Post-Transplant Events in Renal Transplant Patients in Germany (The Portrait Study)

    Nov 1, 2012, 00:00

  • PHP69 Factors May Influence Pattern of Medicine'S Use

    Nov 1, 2012, 00:00

  • PHP14 2010-2012 Global Health Care Reforms and Their Impact on Pricing, Access and Health Outcomes Strategy

    Nov 1, 2012, 00:00

  • PRM14 Proposed Checking Points to Evaluate Report of Multiple Treatment Comparison (MTC) Analysis in the Submission of New Drug Reimbursement and Pricing Application to the National Health Insurance in Taiwan

    Nov 1, 2012, 00:00

  • PRS37 Quality of Life in Paediatric Asthma From Patient and Their Parents Perspective

    Nov 1, 2012, 00:00

  • PUK19 Antimuscarinic Persistence Patterns in Newly Treated Patients With Overactive Bladder (OAB)- Retrospective Comparative Analysis of Fesoterodine, Solifenacin and Tolterodine

    Nov 1, 2012, 00:00

  • PCV1 Evaluation of Statin-Associated Adverse Events- Analysis of the Incidence and Influence of the Concomitant Use of Potential Interacting Drugs

    Nov 1, 2012, 00:00

  • PCV35 Costs of Treating Cardiovascular Diseases in Germany- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PHP144 Economic Effect of Clinical Trials for Turkey

    Nov 1, 2012, 00:00

  • PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C- Submission to the National Institute for Health and Clinical Excellence (NICE)

    Nov 1, 2012, 00:00

  • PCV68 Economic Evaluation of Initiation With Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension in Spain

    Nov 1, 2012, 00:00

  • PCV7 A Mixed Treatment Comparison (MTC) to Compare the Efficacy of Anti-Thrombotic Agents in the Prevention of Stroke and Systemic Embolism (SE) in Patients with Non-Valvular Atrial Fibrillation (NVAF)

    Nov 1, 2012, 00:00

  • PMS78 Demographİc and Socİoeconomİc Characterİstİcs That Affect Selectİon of İntravenous Versus Subcutaneous İnjectİon Tumor Necrosis Factor Inhİbitors for Rheumatoid Arthritis Patients

    Nov 1, 2012, 00:00

  • PMS42 Cost-Utility of Tocilizumab Monotherapy in Methotrexate Intolerant/Contra-Indicated, Moderate/Severe Rheumatoid Arthritis Patients in Portugal

    Nov 1, 2012, 00:00

  • PND52 Validation of Spanish Version of the Huntington Clinical Self-Reported Instrument (H-CSRI)

    Nov 1, 2012, 00:00

  • PIN65 Cost-Effectiveness of First-Line Antiretroviral Regimens for Human Immunodeficiency Virus (HIV) in Colombia- An Analysis of Lopinavir/Ritonavir (LPV/R) and Darunavir Plus Ritonavir (DRV+RTV) in Treatment-Naïve Patients

    Nov 1, 2012, 00:00

  • PCV29 Health Care Resource Utilization and Costs of Cardioembolic Stroke in the Region of Madrid, Spain- Preliminary Results of CODICE Study

    Nov 1, 2012, 00:00

  • PMS8 The Mortality and Costs from Hip, Vertebral, Wrist and Other Fractures Among Postmenopausal Women in Taiwan

    Nov 1, 2012, 00:00

  • PHS17 Costs of Influenza A(H1N1)2009 Infection During the Pandemic and the Postpandemic-Seasonal Waves

    Nov 1, 2012, 00:00

  • PMH2 Interim Results From the “AUTOR” Study, a European Observational Study in Pediatric Patients With Attention Deficit/Hyperactivity Disorder- Patient Characteristics and 1-Year Costs

    Nov 1, 2012, 00:00

  • PCV73 Prevention of Stroke in Patients With Atrial Fibrillation- Cost-Utility Analysis of Rivaroxaban Versus Warfarin in Slovakia

    Nov 1, 2012, 00:00

  • PCN31 A Cross-Sectional Assessment of the Quality of Life of Cancer Patients and Their Complementary and Alternative Medicines (CAM) Use

    Nov 1, 2012, 00:00

  • HC4 Tapping Into the Asian Pharmaceutical Market- Global Firms Go Local?

    Nov 1, 2012, 00:00

  • PDB77 Characteristics of Patients With Diabetes in Southwestern Ontario, Canada

    Nov 1, 2012, 00:00

  • PIN56 Economic Value of Telaprevir for the Treatment of Previously Untreated F2 Fibrosis Chronic Hepatitis C Patients

    Nov 1, 2012, 00:00

  • PMS58 Frequency of Administration of Biologics has an Impact on Treatment Decision Making

    Nov 1, 2012, 00:00

  • PUK1 Diuretic Activity of Aqueous Extract of Boswellia Serrata Roxb. Oleo Gum in Normal Albino Rats

    Nov 1, 2012, 00:00

  • PDB16 Prospective and Retrospective Safety Review of Pioglitazone in a Medical Center

    Nov 1, 2012, 00:00

  • PHP92 The Impact of the Surveillance in Pharmacotherapy by Hospital Health Care Risks Management (HHRM)

    Nov 1, 2012, 00:00

  • PCN75 Survival and Costs in Metastatic Renal Cell Carcinoma- A Comparison of mRCC Treatment Pre- and Post Tyrosine Kinase Inhibitor (TKI) Introduction Using Retrospective Registry Data

    Nov 1, 2012, 00:00

  • PCV22 A Simple Risk Score Identifies Individuals, in European Settings, More Likely to Incur Higher Medical Costs

    Nov 1, 2012, 00:00

  • PMD62 Cost-Effectiveness in Diagnostic Tests- Comparison of the IBD Pre-Endoscopic Screening F-Calprotectin Test Versus Serologic Markers in Selected European Markets

    Nov 1, 2012, 00:00

  • PHS23 Direct Medical Costs Associated With Stroke in Non-Valvular Atrial Fibrillation in India

    Nov 1, 2012, 00:00

  • PMS21 Functional Impairment, Disease Activity, and Duration of Disease Independently Affect the Quality of Life in Patients with Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PHP97 The Regional Distribution of Disabled Pensioners of Hungary

    Nov 1, 2012, 00:00

  • PND30 Cost Analysis of Glatiramer Acetate Versus Fingolimod for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis in Spain

    Nov 1, 2012, 00:00

  • PCV31 Cost of Cardiovascular Diseases in Serbia

    Nov 1, 2012, 00:00

  • PGI10 Factors Associated With Treatment Adherence and Persistence in Canadian Patients With Ulcerative Colitis (Uc)- Analysis of Prescription Claims From the Ramq Database

    Nov 1, 2012, 00:00

  • PDB71 Patient Access, Hba1C Knowledge, and Health Outcomes Among Type 2 Diabetes Patients in Brazil

    Nov 1, 2012, 00:00

  • PSS7 C-Reality (Canadian Burden of Diabetic Macular Edema Observational Study)- 6-Month Findings

    Nov 1, 2012, 00:00

  • PCV57 Cost-Effectiveness of Ivabradine in Thai Heart Failure Patient

    Nov 1, 2012, 00:00

  • PCV7 Implementing and Evaluating Pharmacist-Managed Warfarin Service in Inpatient and Outpatient Setting in Taiwan

    Nov 1, 2012, 00:00

  • PCN114 Defining Regulatory Success for Patient-Reported Outcomes (PROs) in Oncology

    Nov 1, 2012, 00:00

  • PDB74 Effective Health Care Budget Planning for Innovative Drugs in Diabetes Treatment in Turkey; From the Perspective of the Social Security Institution (SSI)

    Nov 1, 2012, 00:00

  • PHP164 Payer Information Requirements for Relative Effectiveness Assessment Vary Across Markets and Create Discrepencies in Patient Access to Medicines

    Nov 1, 2012, 00:00

  • HC1 Price Premium for Innovation? Cost Calculation Method in Japan Versus Cost Utility Analysis in South Korea

    Nov 1, 2012, 00:00

  • PRM19 Using Panel Data to Inform Economic Evaluation

    Nov 1, 2012, 00:00

  • PHP132 Time to Market Access for Innovative Drugs in the UK, France, and Belgium

    Nov 1, 2012, 00:00

  • PHS88 Pharmacist House Calls in Home Care in Japan

    Nov 1, 2012, 00:00

  • PHP65 Perceptions Among General Medical Practitioners Towards Implementation of Medication Reconciliation Program for Patients Discharged from Hospitals in Penang, Malaysia

    Nov 1, 2012, 00:00

  • PRM15 Development of a Post-Marketing Requirements (PMR) Database

    Nov 1, 2012, 00:00

  • PCN8 The Association Between Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk in Taiwan- A Population-Based Cohort Study

    Nov 1, 2012, 00:00

  • PSY24 Economic Evaluation of Opioid Substitution Treatment (OST) in Greece

    Nov 1, 2012, 00:00

  • PCN8 Axitinib (AXI) and Best Supportive Care (BSC) in the Treatment of Sunitinib-Refractory Patients With Metastatic Renal Cell Carcinoma (mRCC)- Results of a Simulated Treatment Comparison (STC) Analyses

    Nov 1, 2012, 00:00

  • PHP46 Trends in Prevalence of Drug Use among Dutch Children from 2005 Until 2010

    Nov 1, 2012, 00:00

  • PHP53 Comparative Evaluation of Drug Information Sources Used by Doctors

    Nov 1, 2012, 00:00

  • PND6 Combining RCT and Observational Data in a Mixed Treatment Comparison of Disease-Modifying-Therapies for Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PHP18 The Effect of Law for Economical Use of Medications 2006 on the Catchment Population of Community Pharmacies Between 2007-2010

    Nov 1, 2012, 00:00

  • PSU2 The Incidence of Complications After its Thyroidectomy in Patients With Thyroid Cancer in Korea - Using Health Claim Database

    Nov 1, 2012, 00:00

  • PRS26 Economic Evaluation of Omalizumab in Patients With Uncontrolled Severe Allergic Asthma From the Public Payer Perspective in Brazil

    Nov 1, 2012, 00:00

  • PSU17 The Cost of Surgical Procedure to Remove Adhesions Abdomen or Pelvis in the Brazilian Private Health Care System

    Nov 1, 2012, 00:00

  • PCN16 Clinical Effectiveness Analysis of Sunitinib for the Treatment of Pancreatic Neuroendocrine Tumors

    Nov 1, 2012, 00:00

  • PHP167 The Role of Decision-Analytic Modeling in German Health Technology Assessments

    Nov 1, 2012, 00:00

  • PGI26 Within-Trial Analysis to Estimate the Economically Justifiable Price of Linaclotide in the Treatment of Irritable Bowel Syndrome With Constipation in the UK

    Nov 1, 2012, 00:00

  • PRM39 Evaluation of Patient Centered Outcomes Using Individual Data From a Quality Registry and Patient Reported Abilities and Ratings of Quality in Health Care, in Diabetes Patients in Sweden

    Nov 1, 2012, 00:00

  • PCN137 NICE Technology Appraisals and the Uptake of Breast Cancer Drugs in the UK

    Nov 1, 2012, 00:00

  • PRM3 Turning the Tables to Address the Real Value of Real-World Observational Studies of Novel Anti-Cancer Agents in Multiple Myeloma

    Nov 1, 2012, 00:00

  • PND5 Budget Impact of Oral Prolonged-Release Fampridine for Management of Walking Disability Associated With Multiple Sclerosis in Taiwan

    Nov 1, 2012, 00:00

  • PHP82 The Characteristics of Clinical Trials in Asia

    Nov 1, 2012, 00:00

  • CE4 Cost-Effectiveness of Dabigatran Compared to Genotype-Guided Warfarin Dosing for Stroke Prophylaxis in Atrial Fibrillation Patients

    Nov 1, 2012, 00:00

  • PIH6 Cost-Effectiveness of Rotavirus Immunization in Vietnam- Exploring Impacts of Herd Immunity and Patterns of Breastfeedingof

    Nov 1, 2012, 00:00

  • PRM101 A Think Aloud Study Comparing the Validity and Acceptability of Discrete Choice and Best Worst Scaling Methods

    Nov 1, 2012, 00:00

  • PMS52 Drug Use Profile in a Rheumatoid Arthritis Patient Cohort- A Brazilian Health Management Organization Experience

    Nov 1, 2012, 00:00

  • PCN20 Comparative Efficacy and Economic Evaluation of Dacarbazine and Temozolomide in Treatment of Malignant Melanoma in Iran

    Nov 1, 2012, 00:00

  • PND27 Assessment of Informal Care Provided to Patients With Multiple Sclerosis and Limitation of Personal Autonomy

    Nov 1, 2012, 00:00

  • PHS45 Cost Effectiveness Analysis of a Specialist Service and Adrenaline Injectors in Anaphylaxis

    Nov 1, 2012, 00:00

  • PHP182 Concordance of PRO Labeling Claims Between the FDA and EMA

    Nov 1, 2012, 00:00

  • PIN84 Trends in Prevalence of Antibacterial Drug Use Among Dutch Children From 2005 Until 2010

    Nov 1, 2012, 00:00

  • PIN62 Cost-Effectiveness of Triple Therapy With Telaprevir for the Treatment of Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients in Germany

    Nov 1, 2012, 00:00

  • PCV88 Venous Thromboembolism- A Systematic Literature Review to Identify Multi-Attribute Utility Values for Use in Economic Models

    Nov 1, 2012, 00:00

  • PHP99 Implementation of a Formulary Management Programme in Singapore

    Nov 1, 2012, 00:00

  • PDB36 Glycemic Control and Quality of Life for Patients With Type 2 Diabetes Mellitus in China

    Nov 1, 2012, 00:00

  • PCN88 Cost-Effectiveness Analysis Per Life-Year Gained Based on Predictors of Response for First Line Metastasic Colorectal Cancer Therapy in Spain

    Nov 1, 2012, 00:00

  • PRM142 Use of Body Surface Area As a Determinant of Dose in Cancer Studies

    Nov 1, 2012, 00:00

  • PMD69 Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation in the UK

    Nov 1, 2012, 00:00

  • PHP135 Stakeholders's Views of the Social Insurance Reform in Greece

    Nov 1, 2012, 00:00

  • PMH40 How do Patients Describe Their Depression? - Incorporating the Patient's Voice Into Instrument Development

    Nov 1, 2012, 00:00

  • PHP28 Systematic Review on Factors Affecting Pharmaceutical Expenditures

    Nov 1, 2012, 00:00

  • PHP98 Patients Preferences Versus Physicians Judgment- Is There a Difference in Health Care Decision Making?

    Nov 1, 2012, 00:00

  • PRM24 Methods for Analysis of Censored Cost Data

    Nov 1, 2012, 00:00

  • PHS86 A Population-Based Study of the Resource Utilization and Costs of Treating Resectable Non-Small Cell Lung Cancer

    Nov 1, 2012, 00:00

  • PIH3 Demographic and Clinical Characteristics of Menopausal Women in the University of Michigan Women's Registry Database

    Nov 1, 2012, 00:00

  • PMS16 Economic Burden of Juvenile Idiopathic Arthritis in Russia

    Nov 1, 2012, 00:00

  • PMS5 A Randomized, Placebo Controlled Trial to Compare Safety and Efficacy Between Curcuma Longa Linn Extract [NR-INF-02], Glucosamine Sulphate and Combination of Two in the Treatment of Painful Knee Osteoarthritis

    Nov 1, 2012, 00:00

  • PDB23 Cost Effectiveness of Angipars™ in the Treatment of Diabetic Foot Ulcers in Iran

    Nov 1, 2012, 00:00

  • PHP28 Reasons for Project Discontinuation in the Pharmaceutical Industry

    Nov 1, 2012, 00:00

  • PHP15 Comparison of Health Expenditures and Drug Expenditures in Two Western Balkan Countries

    Nov 1, 2012, 00:00

  • PCN42 Cost of Prostate Image-Guided Radiation Therapy- Results from a Randomized Trial

    Nov 1, 2012, 00:00

  • PIH34 Identifying Individuals with Different Time Preferences in Time Trade-Off Valuations of Hypothetical Health States- A Latent Class Analysis of the US EQ-5D-3L Valuation Data

    Nov 1, 2012, 00:00

  • PCN81 Cost Effectiveness of Pazopanib in Soft Tissue Sarcoma

    Nov 1, 2012, 00:00

  • PHP45 Relapse Prevention After Switching to Risperidone Long-Acting Ingection- 6 Months Mirror Image Study in Japan

    Nov 1, 2012, 00:00

  • PRS6 Prevalence of Selected Conditions in Russia Across Sources

    Nov 1, 2012, 00:00

  • PDB1 Risk Factors for Hypoglycemia Among Veterans With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PR2 Guiding Principles for Providing Effective Access to Medicines in Emerging Markets

    Nov 1, 2012, 00:00

  • PCV65 A Health Economic Evaluation of Omega-3 Acid Ethyl Esters 90 in the Secondary Prevention Post-MI

    Nov 1, 2012, 00:00

  • PRM150 Latent Transition Analysis as a Tool for Analysing Clinical Data

    Nov 1, 2012, 00:00

  • PDB8 Bariatric and Metabolic Surgery in India – Efficacy and Safety of Minimally Invasive Procedures

    Nov 1, 2012, 00:00

  • PDB18 Population Attributable Risk of Microvascular Events Associated With HbA1C, Blood Pressure or Weight in Patients With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119 (current)
  • 120
  • »